// App-Quantinova.ai

: Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone

Researchers

Presenter

  • David Price

Principal Investigators

  • William Henley

  • Victoria Carter

  • Derek Skinner

  • Rebecca Vella

  • Alberto Papi

  • Leonardo M Fabbri

  • Huib Am Kerstjens

  • Nicolas Roche

  • Dave Singh

  • Claus F Vogelmeier

  • Elif Sen

  • José Eduardo Delfini Cançado

  • Elena Nudo

  • Sara Barile

  • George Georges

Medical Centers

  • Respiratory Medicine, University of Ferrara, Ferrara, Italy,

  • Global Medical Affairs, Chiesi Farmaceutici, S.p.A., Parma, Italy

  • Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy.

  • Department of Pulmonary Medicine, Ankara University School of Medicine, Ankara, Turkey

  • Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg, Germany; Member of the German Centre for Lung Research (DZL), Marburg, Germany

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • Section of Respiratory Medicine, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy

  • Department of Pathology, University of Groningen, University Medical Center Groningen,, Groningen, Netherlands

  • Division of Infection, Immunity and Respiratory Medicine, The University of Manchester and Manchester University NHS Foundation Trustof Manchester, Manchester, United Kingdom

  • Santa Casa de Sao Paulo Medical School, Sao Paulo, Brazil

  • Department of Respiratory Medicine, APHP-Centre University of Paris, Cochin Institute, Paris, France

Locations

  • United Kingdom

  • Germany

  • Singapore

  • Italy

  • France

  • Netherlands

  • Turkey

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • beclometasone dipropionate

  • Fluticasone

  • Azelastine/fluticasone propionate

Outcome

  • N/A

Study Design

  • Fixed Dose

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved